276 related articles for article (PubMed ID: 29614522)
1. Contribution of Factor VIII A2 Domain Residues 400-409 to a Factor X-Interactive Site in the Factor Xase Complex.
Takeyama M; Nogami K; Sasai K; Furukawa S; Shima M
Thromb Haemost; 2018 May; 118(5):830-841. PubMed ID: 29614522
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII light chain contains a binding site for factor X that contributes to the catalytic efficiency of factor Xase.
Takeyama M; Wakabayashi H; Fay PJ
Biochemistry; 2012 Jan; 51(3):820-8. PubMed ID: 22224589
[TBL] [Abstract][Full Text] [Related]
3. Factor VIII A3 domain residues 1793-1795 represent a factor IXa-interactive site in the tenase complex.
Takeyama M; Furukawa S; Sasai K; Horiuchi K; Nogami K
Biochim Biophys Acta Gen Subj; 2023 Aug; 1867(8):130381. PubMed ID: 37207906
[TBL] [Abstract][Full Text] [Related]
4. Identification of a protein S-interactive site within the A2 domain of the factor VIII heavy chain.
Takeyama M; Nogami K; Saenko EL; Nishiya K; Ogiwara K; Shima M
Thromb Haemost; 2009 Oct; 102(4):645-55. PubMed ID: 19806249
[TBL] [Abstract][Full Text] [Related]
5. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies.
Matsumoto T; Nogami K; Ogiwara K; Shima M
Thromb Haemost; 2012 Feb; 107(2):288-301. PubMed ID: 22234708
[TBL] [Abstract][Full Text] [Related]
6. Role of factor VIII C2 domain in factor VIII binding to factor Xa.
Nogami K; Shima M; Hosokawa K; Suzuki T; Koide T; Saenko EL; Scandella D; Shibata M; Kamisue S; Tanaka I; Yoshioka A
J Biol Chem; 1999 Oct; 274(43):31000-7. PubMed ID: 10521497
[TBL] [Abstract][Full Text] [Related]
7. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
[TBL] [Abstract][Full Text] [Related]
8. Contribution of factor VIII light-chain residues 2007-2016 to an activated protein C-interactive site.
Takeyama M; Wakabayashi H; Fay PJ
Thromb Haemost; 2013 Feb; 109(2):187-98. PubMed ID: 23224054
[TBL] [Abstract][Full Text] [Related]
9. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.
Jenkins PV; Freas J; Schmidt KM; Zhou Q; Fay PJ
Blood; 2002 Jul; 100(2):501-8. PubMed ID: 12091341
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
Ahmad SS; Scandura JM; Walsh PN
J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
[TBL] [Abstract][Full Text] [Related]
11. The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.
Yada K; Nogami K; Wakabayashi H; Fay PJ; Shima M
Thromb Haemost; 2013 Jun; 109(6):1007-15. PubMed ID: 23467620
[TBL] [Abstract][Full Text] [Related]
12. Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg372.
Nogami K; Saenko EL; Takeyama M; Giddings JC; Yoshioka A; Shima M
Br J Haematol; 2008 Feb; 140(4):433-43. PubMed ID: 18081893
[TBL] [Abstract][Full Text] [Related]
13. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
[TBL] [Abstract][Full Text] [Related]
14. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
[TBL] [Abstract][Full Text] [Related]
15. Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.
Griffiths AE; Rydkin I; Fay PJ
J Biol Chem; 2013 May; 288(21):15057-64. PubMed ID: 23580639
[TBL] [Abstract][Full Text] [Related]
16. Localization of a factor X interactive site in the A1 subunit of factor VIIIa.
Lapan KA; Fay PJ
J Biol Chem; 1997 Jan; 272(4):2082-8. PubMed ID: 8999906
[TBL] [Abstract][Full Text] [Related]
17. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
[TBL] [Abstract][Full Text] [Related]
18. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
Jenkins PV; Dill JL; Zhou Q; Fay PJ
Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domain.
Nogami K; Freas J; Manithody C; Wakabayashi H; Rezaie AR; Fay PJ
J Biol Chem; 2004 Aug; 279(32):33104-13. PubMed ID: 15166225
[TBL] [Abstract][Full Text] [Related]
20. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
Ahmad SS; Walsh PN
Biochemistry; 2005 Oct; 44(42):13858-65. PubMed ID: 16229474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
